In 2012 we will be taking a hard look at recent successes and failures, delivering insights into what the next strategic steps should be, from both R&D and commercial perspectives, to continue the drive towards personalized medicine in oncology. Progress in the development of novel combinations, enabling technologies and therapeutic modalities will be examined in the context of recent drug approvals and the evolving cancer healthcare marketplace.
Gain a better understanding of the ‘big picture’ in the novel oncology therapeutic world, and of how you must adapt your own decision-making to align with ongoing macro trends and developments
Improve your R&D strategy through lessons learned and shared in the form of in-depth case studies from genuine thought leaders
Analyze the evolving marketplace and the oncology R&D business models of your competitors to better differentiate your own product candidates and prepare them for commercial success
Meet numerous senior oncology R&D decision makers from the world’s leading pharm and biotech companies in an exclusive, yet informal environment ideal for networking at the highest levels
Establish yourself and your organization as frontrunners in the race to deliver the next wave of targeted oncology therapeutics